Link: Bird Flu Alert:.
An extract from a much longer article about Tamiflu - a provocative read!
Tamiflu(c), manufactured by Roche, a Swiss company, is the FDA approved medicine purported to be an effective treatment for influenza. It has been around for years but hasn't sold well due to the lack of a large influenza epidemic in the world. The threatened Bird Flu pandemic has changed that. Now stocks of Tamiflu(c) are in great demand and large quantities are impossible to secure. Roche is backlogged for years into the future. World health authorities including the UN's World Health Organization (WHO) are urging Roche to license other companies to make the drug, but they are resisting, claiming the drug-making process takes a year and that it would take new makers three years to get tooled up and that the main ingredient is in limited supply. They have been caught in a lie, however.
Within hours of Roach's public statements about the unfeasibility of allowing other entities to make their newly crowned "blockbuster" drug and perhaps save millions of inhabitants of planet earth, several potential makers, two of them governments have stepped up and revealed their plans to "break" the Tamiflu(c) patent and start production by the end of this year, should a pandemic break out. Taiwan stated yesterday that they already had made the drug in the lab and could commence commercial production within a few months. India made a similar pronouncement in this release.
Though intellectual property such as patents is important to incentivize innovation and research, in the case of Tamiflu(c), "stealing" the patent would seem to be a case of "Turn about is fair play." You see, Tamiflu(c) is but a knock-off of an ancient oriental treatment for coughs and flues. The fruit of the Chinese Star Anise tree is the starting point in the manufacture of this "modern" wonder drug. Chinese medical practitioners have used a tea of this licorice-tasting spice to treat respiratory problems for hundreds, if not thousands of years. The fruit of this Magnolia-like tree is being quickly scooped up by enterprising thinkers around the world and large, commercial quantities are already in short supply. Once the small quantities currently in the supply chain are gone, further Star Anise will not be available till the harvest next March. Roche claims to be able to synthesize the shikimic acid which is the substance extracted from Star Anise in the first stage of the manufacturing of Tamiflu(c). This reporter has at least a mild curiosity as to whether all the complex processing of making Tamiflu(c) is necessary to make a good flu treatment.